论文部分内容阅读
目的:探讨在老年糖尿病患者临床治疗过程中,甘精胰岛素联合格列美脲治疗方法的应用效果。方法:选取2014年8月至2015年9月本院收治的老年糖尿病患者82例,随机均匀分成观察组与对照组,对照组患者主要进行常规格列美脲及诺和灵药物治疗,观察组患者主要进行甘精胰岛素联合格列美脲治疗,研究分析两组患者临床治疗有效情况。结果:在患者血糖和胰岛功能改善情况上比较,观察组明显优于对照组(P<0.05)。在患者临床治疗有效率上比较,观察组明显高于对照组(P<0.05)。且在患者后期不良反应发生率上比较,观察组明显低于对照组(P<0.05)。结论:甘精胰岛素联合格列美脲在老年糖尿病患者治疗中的应用价值较大。
Objective: To investigate the clinical effects of glargine and glimepiride in the treatment of elderly diabetic patients. Methods: From August 2014 to September 2015, 82 elderly diabetic patients admitted to our hospital were randomly divided into observation group and control group. Patients in the control group were treated with conventional glimepiride and Novolin, and the observation group Patients mainly glargine combined with glimepiride treatment, analysis of two groups of patients with clinical treatment effective. Results: Compared with the control group (P <0.05), the observation group was significantly better than the control group in the improvement of blood glucose and islet function. In patients with clinical treatment efficiency comparison, the observation group was significantly higher than the control group (P <0.05). And in patients with late adverse reactions, the observation group was significantly lower than the control group (P <0.05). Conclusion: Glargine and glimepiride are of great value in the treatment of elderly diabetic patients.